This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Covidien AG
Covidien AG, a prominent player in the global healthcare sector, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 2000, the company has established itself as a leader in the medical device and supplies industry, focusing on innovative solutions for surgical and medical applications. Specialising in advanced surgical instruments, respiratory products, and medical imaging technologies, Covidien AG is renowned for its commitment to quality and innovation. The company’s unique offerings, such as minimally invasive surgical devices, have significantly enhanced patient outcomes and operational efficiency in healthcare settings. With a strong market position, Covidien AG has achieved numerous accolades for its contributions to medical technology, solidifying its reputation as a trusted partner in the healthcare community.
DitchCarbon Score
How does Covidien AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Land Transportation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Covidien AG's score of 38 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Covidien AG, headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Medtronic plc, which influences its climate commitments and reporting practices. Covidien AG's climate initiatives and reduction targets are inherited from its parent company, Medtronic plc. Medtronic has established various sustainability goals, including commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets for Covidien AG have not been detailed. As part of its corporate family, Covidien AG aligns with Medtronic's broader climate strategies, which focus on reducing greenhouse gas emissions across all scopes. The absence of direct emissions data highlights the need for ongoing transparency and commitment to climate action within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Covidien AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
